The inhibitory effect of multiple sclerosis and control sera on certain myelin-catabolizing enzymes.
D001192:Arylsulfatases / Q000037:antagonists & inhibitors*; D001921:Brain / Q000201:enzymology; D005696:Galactosidases / Q000037:antagonists & inhibitors*; D005698:Galactosylceramidase / Q000037:antagonists & inhibitors*; D006801:Humans; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid / Q000201:enzymology*; D009186:Myelin Sheath / Q000378:metabolism*; D011480:Protease Inhibitors; D013429:Sulfatases / Q000037:antagonists & inhibitors*
D011480:Protease Inhibitors; D013429:Sulfatases; D001192:Arylsulfatases; D005696:Galactosidases; D005698:Galactosylceramidase